Roberts David B 4

What Happened

• David B. Roberts, President and Director of Lemaitre Vascular (LMAT), was credited with nine dividend-equivalent rights on 2026-03-26 totaling 18.084 shares. Each item was reported as an award/other acquisition (code A) at $0.00 per share (derivative instrument), so no cash changed hands on the Form 4.
• These dividend-equivalent rights are the economic equivalent of common shares and vest proportionately with previously granted restricted stock units (RSUs) and performance share units (PSUs). The awards were not open-market purchases or sales and thus are administrative/compensation-related, not immediate signals of buying or selling.

Key Details

• Transaction date: 2026-03-26; Filing date: 2026-03-30 (filed within the 2-business-day Form 4 deadline).
• Amount credited: nine entries totaling 18.084 dividend-equivalent rights; price reported $0.00 (derivative award).
• Shares owned after transaction: not specified in the provided excerpt of the filing.
• Footnotes: each line represents dividend equivalents that accrued on earlier awards and vest with those awards — F1/F2: awards from 12/12/2022; F3/F4: 12/08/2023; F5/F6: 12/06/2024; F7/F8: 02/18/2025; F9: 12/10/2025. Each dividend equivalent equals one share of common stock.
• No 10b5-1 plan, sale, gift, or tax-withholding action is indicated in this transaction.

Context

• Dividend-equivalent rights are typically administrative credits that mirror dividends on outstanding RSUs/PSUs and vest according to the original award terms; they do not represent a market purchase or sale. They generally reflect compensation mechanics rather than a direct insider signal to buy or sell stock.